Johnson & Johnson said on Wednesday Canada gave full approval to its single-shot COVID-19 vaccine for people aged 18 years and older, making it the first full approval for the vaccine globally.
The vaccine was previously authorized by the country under an interim order.
Canada, which is reporting 2,563 infections on average each day and has administered at least 60,101,058 doses of COVID-19 vaccines so far, gave full approval to Moderna Inc and Pfizer Inc’s coronavirus vaccines in September.
The country authorized the use of Pfizer’s COVID-19 vaccine for children aged 5 to 11 and a booster dose for people aged 18 years and older this month.
J&J’s coronavirus vaccine has been authorized for emergency use in many countries, including the United States.
The news comes as a limited supply of Johnson & Johnson‘s single-dose Janssen COVID-19 vaccine will be made available to eligible Saskatchewan residents starting this Wednesday.
The Saskatchewan government announced Tuesday that an initial supply of 2,500 doses will be administered through multiple Saskatchewan Health Authority (SHA) clinics on a first-come, first-serve basis.
The vaccine is available to residents 18 years of age and older.
“Due to the limited number of doses received and potential demand, these doses will be available on a walk-in basis at (select) locations only,” noted the government in its announcement on Tuesday. “Janssen appointments cannot be booked online through the Patient Booking System.”
Clinics are planned for Regina, Saskatoon, Estevan, Prince Albert, Melfort, Swift Current, North Battleford and Lloydminster. Residents are encouraged to check SHA clinic location information online for up-to-date locations, dates and times before travelling.
The SHA clinics will be set up to permit walk-ins to be screened to receive the Janssen vaccine upon request. The government notes that inclement weather may delay vaccine deliveries.
This content is also available in: Tiếng Việt